A conference to review the progress of discovery efforts in a group of more than 1,340 lawsuits against manufacturers of testosterone treatments is scheduled for April 21, and the first case is expected to go trial in the fall of 2016. The lawsuits were consolidated in U.S. District Court in the Northern District of Illinois and target seven testosterone makers claiming the drugs caused heart attacks, strokes and other health problems. Testosterone treatments are prescription hormones that are designed to treat hypogonadism, a condition in which men do not produce enough testosterone due to injury or disease. Pharmaceutical companies have ... Read More
Righting Injustice is published by the Beasley Allen Law Firm. If you are interested in a free legal consultation, please take a few moments to fill out the contact form with as many details as possible. The more information you provide us, the better we can evaluate your claim.